medigraphic.com
ISSN 1995-9427 (Print)

2019, Number 2

<< Back Next >>

Invest Medicoquir 2019; 11 (2)

Hyperbaric oxygen in patients with chronic coronary disease

Iglesias GM, Estrada PJG, Travieso MM, Demósthenes SA

Language: Spanish
References: 39
Page: 1-18
PDF size: 262.84 Kb.


ABSTRACT

Introduction. Heart diseases constitute an important health problem. Within these diseases the ischemic heart disease to demonstrate the bigger death rates universal has special relevance. There are positive results in the use of the hyperbaric oxygen in patients with cardiovascular diseases. They try to describing the effect of the hyperbaric oxygenation in the evolution of patients with chronic coronary artery disease. Methods. A descriptive, longitudinal, prospective study came true. Of the 98 patients appreciated with chronic ischemic heart disease, only 51 were treated with hyperbaric oxygenation in the period January 2010 to July of 2013. They excluded themselves them under 18 elderly years, pregnant women, denied to investigation, and the ones that did not conclude the 3 cycles of treatment. 10 sessions gave every three months with hyperbaric oxygenation in camera multi-plaza themselves HAUX to 2.2 TIES during 50 minutes. Information processing came true by means of the statistical package SPSS version 13,0 for Windows. Descriptive measures of summary were used: Stocking and standard deviation for them quantitative and percentage for the qualitative. Results. The Middle Ages belonged to 65,5±10,3 years, with a predominance of the masculine sex (76,5 %). 39,2 % of the total, had a lessened ejection fraction left ventricular. Improvement of the symptoms like stuffiness, pain at rest were observed and to the effort in a 82,6 %, 95,8 % and 84,0 % respectively decrease of the dose of nitrite in a 93,9%, as well as frequency, intensity and duration of the anginous crises. They did not improve the signs of edema, arrhythmias and third noise. Conclusions. It was concluded that the hyperbaric oxygenation is an useful treatment in the patient bearers of chronic ischemic heart disease.


REFERENCES

  1. Obregón AG. Manual de Cardiología Intervencionista. La Habana: CIMEQ; 2010;183-213. 14

  2. Woodward TS. Cecil. Tratado de medicina interna. 20 ed. Madrid: McGraw-Hill / Interamericana; 1998;1:194-198.

  3. Dirección Nacional de estadísticas del MINSAP. Anuario estadístico. Cuba: MINSAP (Internet). 2015 (Citado 24 marzo 2017). Disponible en: files.sld.cu/dne/files/2016/04/Anuario_2015_electronico-1.pdf

  4. Ferreira-González I. Epidemiología de la enfermedad coronaria. Rev.Esp.Cardiol (Internet). 2014 (Citado 24 marzo 2017); 67 (2):139-44. Disponible en: http://www.revespcardiol/org/es/epidemiologia-enfermedad-coronaria/articulo/90267578/

  5. Thompson GR, Partridge J. Coronary calcification score: the coronary-risk impact factor. Lancet (Internet). 2004 (Citado 24 marzo 2017); 363:557-9. Disponible en: http://www.kardiolab.ch/EBCTEditorialLancet022004.pdf

  6. Rawlws J. Great: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis. Heart (Internet) 2003; 89(5):563-4. Citado 24 marzo 2017. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1767631/

  7. Boix Martínez R, Aragonés Sanz N, Medrano Albero MJ. Tendencias en la mortalidad por cardiopatía isquémica en 50 provincias españolas. Rev.Esp.Cardiol. (Internet). 2003 (Citado 24 marzo 2017); 56 (9): 850-856. Disponible en: http://www.revespcardiol.org/es/tendencias-mortalidad-por-cardiopatia-isquemica/articulo/13051611/

  8. Madrazo Ríos JM, Madrazo Machado AM. Actuales factores de riesgo alergénico en la génesis de la cardiopatía isquémica .Problemática epidemiológica mundial. Rev.cub.invest.biomed. (Internet). 2005 (Citado 24 marzo 2017); 24 (2): 48-50. Disponible en: http://scielo.sld.cu/pdf/ibi/v24n2/ibi10205.pdf

  9. Churchill-Davidson I, Sanger C, Thomlinson I. High pressure oxygen and radiotherapy. Lancet. 1955 May 28;268(6874):1091-5.

  10. Boerema I, Kroll J, Meijne NG, Lokin E, Kroon B, Huiskes JW. High atmospheric pressure as an aid to cardiac surgery. Arch Chir Neerl. 1956;8(3):193-211.

  11. Boerema I, Meyne NG, Brummellamp WK. Life without blood. J Cardiovasc Surg 1960;1(1):133-146.

  12. Swift P, Turner J, Oxer H, O'Shea J, Lane G, Woollard K. Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal 15 (Internet) 1992 Nov (Citado 2 mayo 2017); 124(5): 1151-1158. Disponible en: http://www.sciencedirect.com/science/article/pii/000287039290394B

  13. Nápoles Riaño D. Tratamiento del infarto agudo del miocardio, oxigenación hiperbárica en pacientes no tributarios de tratamiento con estreptoquinasa recombinante. En Intervención comunitaria e intersectorial por un ambiente saludable. 2000. p. 46-46.

  14. Swift PC, Turner JH, Oxer HF, O´Shea J, Lane GK, Woollard MD. Myocardial Hibernation Identified by Hyperbaric Oxygen Treatment and Echocardiography in Postinfarction Patients: Comparison with Exercise Thallium Scintigraphy. American Heart Journal (Internet) 1992 nov (Citado 2mayo 2017); 124 (5):1151-1158. Disponible en: https://doi.org/10.1016/0002-8703(92)90394-B

  15. Weiss LD, Van Meter KW. The Applications of Hyperbaric Oxygen Therapy in Emergency Medicine. American Journal of Emergency Medicine 1992;10(6):558-568.

  16. Ellestad MH, Shandling AH, Hart GB, Crump R, Marlow D, Van Natta B, et al: Hyperbaric Oxygen and Thrombolysis in Myocardial Infarction. The “Hot MI” Study. Cardiology. 1998 Oct;90(2):131-6.

  17. Ellestad MH. Hyperbaric oxygen: its application in cardiology: a historical perspective and personal journey. Cardiol Rev. 2009 Nov-Dec;17(6):280-2.

  18. Rohlfs I, García MM, Gavaldà L, Medrano MJ, Juvinyà D, Baltasar A, et al. Género y cardiopatía isquémica. Barcelona: Gac Sanit (Internet) 2004 sept-oct (Citado 2 mayo 2017) 18(5). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112004000500008

  19. Weiss LD, Van Meter KW. The Applications of Hyperbaric Oxygen Therapy in Emergency Medicine. American Journal of Emergency Medicine 1992;10(6):558-568.

  20. Borges Helps A. Cardiopatía isquémica oculta: un reto al diagnóstico médico. La Habana: Rev Cub Med Mil. 2007 oct-dic; 36(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572007000400001

  21. Rodríguez NAY, Naranjo DAA, Aroche AR. Factores de riesgo en pacientes con síndrome coronario agudo remitidos para coronariografía. Cor Salud (Internet) 2013 (Citado 2 mayo 2017); 5(3). Disponible en: http://new.medigraphic.com/cgi-bin/resumen.cgi?IDARTICULO=56559 16

  22. Barrios V, Escobar C, Bertomeu V, Murga N, de Pablo C, Calderón A. Control de los factores de riesgo en los pacientes hipertensos con cardiopatía isquémica crónica atendidos en las consultas de cardiología. Estudio CINHTIA. Revista Clínica Española (Internet) 2008 sep (Citado 2 mayo 2017); 208 (8):400-404. Disponible en: http://www.sciencedirect.com/science/article/pii/S0014256508759976

  23. Zamora A, Marrugat J. Pronóstico de los pacientes diabéticos con cardiopatía isquémica. Rev Esp Cardiol (Internet) 2002 julio (Citado 2 mayo 2017), 55(7): 751-762. Disponible en: http://www.revespcardiol.org/es/pronostico-los-pacientes-diabeticos-con/articulo/13034191/

  24. Soto M, Failde I. La calidad de vida relacionada con la salud como medida de resultados en pacientes con cardiopatía isquémica. Rev Soc Esp Dolor (Internet) 2004 (Citado 2 mayo 2017); 11:505-14. Disponible en: http://scielo.isciii.es/pdf/dolor/v11n8/revision2.pdf

  25. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, BakiTT, et al. Off-Label Stent Therapy. 2-Year Comparison of Drug-Eluting Versus Bare-Metal Stents. J Am Coll Cardiol (Internet) 2008 feb (Citado 2 mayo 2017); 51(6):607-14. Disponible en: http://www.sciencedirect.com/science/article/pii/S073510970703666

  26. Braga Yu CY, Rivetti LA, Stella FP. Efectividad y Seguridad de los Stents Farmacológicos en un Servicio de Cardiología en Curitiba-PR. Arq Bras Cardiol (Internet) 2010 julio (Citado 2 mayo 2017); 95(1). Disponible en: http://www.scielo.br/scielo.php?pid=S0066-782X2010001100002&script=sci_arttext&tlng=es

  27. Torres Hernández ME, Yánez Rivera TG, Ross Mayo J, García- Magaña A, De la Cruz Zurita H, Priego Brindis JT, et al. Resultados inmediatos y a largo plazo de angioplastia con stent farmacológico (paclitaxel) y no farmacológico: Un estudio prospectivo, comparativo en el IMSS Villahermosa. Rev Mex Cardiol (Internet) 2007 jul-sept (Citado 2 mayo 2017); 18 (3): 95-102. Disponible en: http://www.medigraphic.com/pdfs/cardio/h-2007/h073a.pdf

  28. Bennett MH, Lehm JP, Jepson N. Hyperbaric oxygen therapy for acute coronary syndrome. Cochrane Database Syst Rev (Internet) 2015 julio (Citado 2 mayo 2017); 23(7). Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26202854

  29. Swift PC, Turner JH, Oxer HF, O´Shea J, Lane GK, Woollard MD. Myocardial Hibernation Identified by Hyperbaric Oxygen Treatment and Echocardiography in Postinfarction Patients: Comparison with Exercise Thallium Scintigraphy. 17 American Heart Journal (Internet) 1992 nov (Citado 2 mayo 2017); 124 (5):1151-1158. Disponible en: https://doi.org/10.1016/0002-8703(92)90394-B

  30. Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S. Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. Cardiovasc Revasc Med (Internet) 2010 Marzo (Citado 2 mayo 2017); 11(1):8-19. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/20129356

  31. Desola J. Bases y fundamento terapéutico de la oxigenoterapia hiperbárica. Revista Virtual de Medicina Hiperbárica (Internet) 1998 (Citado 25 abril 2017); 54(1260). Disponible en: http://www.cccmh.com/BasesOHB.htm

  32. García Covarrubias L, Sánchez Rodríguez E. Terapia con oxigenación hiperbárica, concepto básico. Gac Med Mex. 2000;136(1):45-56.

  33. O’Neill W, Martin J, Dixon S, Bartorelli A, Trabattoni D, Spears J, et al. Acute Myocardial Infarction With Hyperoxemic Therapy (Amihot): A Prospective, Randomized Trial of Intracoronary Hyperoxemic Reperfusion After Percutaneous Coronary Intervention. Journal of the American College of Cardiology (Internet) 2007 July (Citado 25 abril 2017); 50(5): 397-405. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/17662390

  34. Babul S, Rhodes EC. The role of hyperbaric oxygen therapy in sports medicine. Sports Medicine (Internet) 2000 (Citado 2 mayo 2017); 30(6):395-403. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/11132122

  35. Sterling DL, Thornton JD, Swafford A, Gottlieb SF, Bishop SP, Stanley AW, et al. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation (Internet) 1993 (Citado 2 mayo 2017); 88(4):1931-1936. Disponible en: http://circ.ahajournals.org/content/circulationaha/88/4/1931.full.pdf

  36. Dekleva M, Neskovic A,Vlahovic A, Putnikovic B, Beleslin B, Ostojic M. Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. Am.Heart.J. (Internet). 2004 Oct (Citado 2 mayo 2017); 148(4):14. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15459609

  37. Li Y, Dong H, Chen M, Liu J, Yang L, Chen S, et al. Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, 18 randomized, controlled clinical trial. Cardiothorac Vasc Anesth (Internet). 2011 Dec; 25(6):908-16.

  38. Cabigas BP, Su J, Hutchins W, Shi Y, Schaefer RB, Recinos RF, et al. Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res (Internet) 2006 (Citado 2 mayo 2017); 72 (1): 143-151. Disponible en: https://academic.oup.com/cardiovascres/article/72/1/143/296277/Hyperoxic-and-hyperbaric-induced-cardioprotection

  39. Pérez Ruiz A, Rodríguez Calzadilla A, Sanjurjo Gómez VM, Padrón Chacón R. El papel de óxido nítrico en la hemodinámica, hemostasia e inflamación. Rev Cubana Estomatol 1997 jul-dic; 34 (2):84-86.




2020     |     www.medigraphic.com